1. 1 Cole WH: Efforts to explain spontaneous regression of cancer. J Surg Oncol 17:201-209, 1981
2. 2 Ricci SB, Cerchiari U: Spontaneous regression of malignant tumors: Importance of the immune system and other factors (Review). Oncol Lett 1:941-945, 2010
3. 3 Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, et al.: Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 86:58-65, 2007
4. 4 Murase T, Nakamura S, Kawauchi K, Matsuzaki H, Sakai C, et al.: An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol 111:826-834, 2000
5. 5 Oki Y, Ogura M, Kato H, Kikuchi A, Kagami Y, et al.: Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. Cancer Sci 99:179-184, 2008